Precision Medicine Brochure

November 18, 2019

Recent data suggests that clinical trials using biomarkers – including genomic biomarkers – are twice as likely to succeed versus those that don’t.1 According to a 2018 analysis, The Innovation Imperative: The Future of Drug Development, by the Economist Intelligence Unit (EIU) and commissioned by Parexel, drugs developed using innovative trial methods, including precision medicine trial designs, are adopted by payers more quickly.2 In short, payers want to know which patients are more likely to avoid making reimbursements for ineffective treatments.

Previous Article
Podcast: Driving Drug Development Innovation Through Patient Centricity
Podcast: Driving Drug Development Innovation Through Patient Centricity

This PharmaVoice podcast explores patient-centric trials as a key innovation in drug development.

Next Flipbook
Parexel Adaptive Trial Design Brochure
Parexel Adaptive Trial Design Brochure

Learn how Parexel can help you successfully implement Adaptive Trial Designs.

Contact Us with your Biotech needs!

Email Us